Glaucoma In Global Market: Industry Analysis, Size, Trends & Outlook, 2017 - 2021

Researchmoz added Most up-to-date research on "Glaucoma In Global Market: Industry Analysis, Size, Trends & Outlook, 2017 - 2021" to its huge collection of research reports.

Glaucoma is a group of eye diseases which result in damage to the optic nerve and vision loss. The most common type is open-angle glaucoma with less common types including closed-angle glaucoma and normal-tension glaucoma. Open-angle glaucoma develops slowly over time and there is no pain. Side vision may begin to decrease followed by central vision resulting in blindness, if not treated. Closed-angle glaucoma can present gradually or suddenly. The sudden presentation may involve severe eye pain, blurred vision, mid-dilated pupil, redness of the eye, and nausea. Vision loss from glaucoma, once it has occurred, is permanent.

Though, glaucoma cannot be cured completely but the disease progression can be controlled with the help of available treatments. There are three types of modalities available for treatment of glaucoma: Drugs, Laser and Invasive Surgery. Further, based upon the approaches employed for the medication, it can be segmented into two parts: PGA Medication and Non-PGA Medication. The PGA approach reduces IOP with the help of prostaglandin (PGA). The non-PGA medication can be further divided into four sub segments: Beta blockers, Alpha blockers, Carbonic anhydrase inhibitors (CAIs) and Combination Products.

Several factors such as rising prevalence of diabetes, growing geriatric population and rising health care expenditure along with increasing disposable income and growing obese population will drive the market growth in the next few years. Development of new drugs & devices and drug therapy focused upon IOP are the few notable market trends. However, high cost of treatment, severe side effects and hasty drug approval processes act as a major roadblock for the market growth.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1109589

The report “Global Glaucoma Market: Industry Analysis & Outlook (2017-2021)” analyzes the development of this market, with focus on the US and OUS treatment market. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Pfizer Inc., Novartis AG, Merck & Co., Inc. and Allergan Plc. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global glaucoma market along with the study of the US market.

Table of Content

1. Overview
1.1 Glaucoma
1.2 Causes & Types
1.3 Symptoms & Diagnosis
1.4 Treatment Methods
1.5 Glaucoma Pharmaceutical Market Segmentation

2. Global Glaucoma Market
2.1 Global Glaucoma Market Forecast by Value
2.2 Global Glaucoma Market by Segments
2.3 Global Glaucoma Drugs Market Forecast by Value
2.4 Global Glaucoma Market by Drug Class
2.5 Global Glaucoma Drugs Market by Region
2.6 Global Glaucoma Patient Volume Forecast

3. Regional Markets
3.1 The US
3.1.1 The US Glaucoma Drugs Market Forecast by Value
3.1.2 The US Glaucoma Patient Volume Forecast
3.1.3 The US Open Angle Glaucoma Patient Volume Forecast
3.1.4 The US Glaucoma Prescription Volume Forecast
3.1.5 The US Glaucoma Drugs Market by Type

Browse More Details @ http://www.researchmoz.us/global-glaucoma-market-industry-analysis-outlook-20172021-report.html

Comprehensive Analysis & Treatments Available For Global Glaucoma Market: Industry Analysis & Outlook, 2017 - 2021

Researchmoz added Most up-to-date research on "Comprehensive Analysis & Treatments Available For Global Glaucoma Market: Industry Analysis & Outlook, 2017 - 2021" to its huge collection of research reports.

Glaucoma is a group of eye diseases which result in damage to the optic nerve and vision loss. The most common type is open-angle glaucoma with less common types including closed-angle glaucoma and normal-tension glaucoma. Open-angle glaucoma develops slowly over time and there is no pain. Side vision may begin to decrease followed by central vision resulting in blindness, if not treated. Closed-angle glaucoma can present gradually or suddenly. The sudden presentation may involve severe eye pain, blurred vision, mid-dilated pupil, redness of the eye, and nausea. Vision loss from glaucoma, once it has occurred, is permanent.

Though, glaucoma cannot be cured completely but the disease progression can be controlled with the help of available treatments. There are three types of modalities available for treatment of glaucoma: Drugs, Laser and Invasive Surgery. Further, based upon the approaches employed for the medication, it can be segmented into two parts: PGA Medication and Non-PGA Medication. The PGA approach reduces IOP with the help of prostaglandin (PGA). The non-PGA medication can be further divided into four sub segments: Beta blockers, Alpha blockers, Carbonic anhydrase inhibitors (CAIs) and Combination Products.

Several factors such as rising prevalence of diabetes, growing geriatric population and rising health care expenditure along with increasing disposable income and growing obese population will drive the market growth in the next few years. Development of new drugs & devices and drug therapy focused upon IOP are the few notable market trends. However, high cost of treatment, severe side effects and hasty drug approval processes act as a major roadblock for the market growth.

The report “Global Glaucoma Market: Industry Analysis & Outlook (2017-2021)” analyzes the development of this market, with focus on the US and OUS treatment market. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Pfizer Inc., Novartis AG, Merck & Co., Inc. and Allergan Plc. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global glaucoma market along with the study of the US market.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1109589

Table of Content

1. Overview
1.1 Glaucoma
1.2 Causes & Types
1.3 Symptoms & Diagnosis
1.4 Treatment Methods
1.5 Glaucoma Pharmaceutical Market Segmentation

2. Global Glaucoma Market
2.1 Global Glaucoma Market Forecast by Value
2.2 Global Glaucoma Market by Segments
2.3 Global Glaucoma Drugs Market Forecast by Value
2.4 Global Glaucoma Market by Drug Class
2.5 Global Glaucoma Drugs Market by Region
2.6 Global Glaucoma Patient Volume Forecast

3. Regional Markets
3.1 The US
3.1.1 The US Glaucoma Drugs Market Forecast by Value
3.1.2 The US Glaucoma Patient Volume Forecast
3.1.3 The US Open Angle Glaucoma Patient Volume Forecast
3.1.4 The US Glaucoma Prescription Volume Forecast
3.1.5 The US Glaucoma Drugs Market by Type
3.1.6 The US Glaucoma First Line Drugs Market Forecast by Value

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1109589

Current And Future Prospects Of Glaucoma Therapeutics Global Market During The Forecast Period 2017 - 2024

ResearchMoz presents this most up-to-date research on "Current And Future Prospects Of Glaucoma Therapeutics Global Market During The Forecast Period 2017 - 2024".

Glaucoma Therapeutics Market: Overview 

Glaucoma is an ocular disease which affects the optic nerve of the iris and progression of the same results into vision loss and blindness. The treatment for glaucoma starts with topical eye drops belonging to the class of prostaglandins, beta blockers, alpha agonist, combined medication, carbonic anhydrase inhibitor and cholinergic. Administration of these eye drops reduces the production of the fluid inside eyes thereby reducing the intraocular pressure. Using topical eye drops is an alternative for surgery or delays the surgical procedure. This report analyzes the current and future prospects of the glaucoma therapeutics market based on type of drug class, end user and geography.

Glaucoma Therapeutics Market: Scope and Methodology

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of the major glaucoma therapeutics market in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for each by drug class, end user, and geography for the period 2014 to 2024, considering the macro and micro environmental factors. The revenue generated from each product was calculated by considering number of products used in the procedures and their market demand as per their use, number of product launched, average cost of products of each sub segment, trends in industry, end user trend, and adoption rate across all the geographies. The revenue generated for drug class was calculated on the basis of prevalence of diseases, and number of people affected by the disease

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on drug class, end-user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the glaucoma therapeutics market in the current and future scenario.

Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The study also covers detailed country analysis contributing majorly in the glaucoma therapeutics market.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=893347

Glaucoma Therapeutics Market: Competitive Landscape

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the glaucoma therapeutics market are Allergan Inc., Merck & Co., Pfizer Inc., Novartis AG., Santen Pharmaceuticals, Valeant Pharmaceuticals and Aerie Pharmaceuticals.

The glaucoma therapeutics market has been segmented as follows:

Glaucoma Therapeutics Market, by Drug Class

• Alpha Agonist
• Beta Blockers
• Prostaglandin Analogs
• Carbonic Anhydrase Inhibitor
• Cholinergic
• Combined Medication

Glaucoma Therapeutics Market, by End Users

• Ophthalmic clinic
• Hospitals
• Ambulatory Surgical Centers

Glaucoma Therapeutics Market, by Geography

• North America
• U.S.
• Canada
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Europe
• U.K.
• Germany
• Spain

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=893347

Therapeutics Global Market For Glaucoma - Share, Volume, Growth, Trends, and Forecast 2017 - 2024

ResearchMoz presents this most up-to-date research on "Therapeutics Global Market For Glaucoma - Share, Volume, Growth, Trends, and Forecast 2017 - 2024".

Glaucoma Therapeutics Market: Overview 

Glaucoma is an ocular disease which affects the optic nerve of the iris and progression of the same results into vision loss and blindness. The treatment for glaucoma starts with topical eye drops belonging to the class of prostaglandins, beta blockers, alpha agonist, combined medication, carbonic anhydrase inhibitor and cholinergic. Administration of these eye drops reduces the production of the fluid inside eyes thereby reducing the intraocular pressure. Using topical eye drops is an alternative for surgery or delays the surgical procedure. This report analyzes the current and future prospects of the glaucoma therapeutics market based on type of drug class, end user and geography.

Glaucoma Therapeutics Market: Scope and Methodology

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of the major glaucoma therapeutics market in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for each by drug class, end user, and geography for the period 2014 to 2024, considering the macro and micro environmental factors. The revenue generated from each product was calculated by considering number of products used in the procedures and their market demand as per their use, number of product launched, average cost of products of each sub segment, trends in industry, end user trend, and adoption rate across all the geographies. The revenue generated for drug class was calculated on the basis of prevalence of diseases, and number of people affected by the disease

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on drug class, end-user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the glaucoma therapeutics market in the current and future scenario.

Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The study also covers detailed country analysis contributing majorly in the glaucoma therapeutics market.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=893347

Glaucoma Therapeutics Market: Competitive Landscape

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the glaucoma therapeutics market are Allergan Inc., Merck & Co., Pfizer Inc., Novartis AG., Santen Pharmaceuticals, Valeant Pharmaceuticals and Aerie Pharmaceuticals.

The glaucoma therapeutics market has been segmented as follows:

Glaucoma Therapeutics Market, by Drug Class

• Alpha Agonist
• Beta Blockers
• Prostaglandin Analogs
• Carbonic Anhydrase Inhibitor
• Cholinergic
• Combined Medication

Glaucoma Therapeutics Market, by End Users

• Ophthalmic clinic
• Hospitals
• Ambulatory Surgical Centers

Glaucoma Therapeutics Market, by Geography

• North America
• U.S.
• Canada
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Europe
• U.K.
• Germany

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=893347

Comprehensive Information On Therapeutic Development For Open-Angle Glaucoma, H1 2017

ResearchMoz presents this most up-to-date research on "Comprehensive Information On Therapeutic Development For Open-Angle Glaucoma, H1 2017".

Global Markets Directs, Open-Angle Glaucoma Pipeline Review, H1 2015, provides an overview of the Open-Angle Glaucomas therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Open-Angle Glaucoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Open-Angle Glaucoma and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=245117

Scope

• The report provides a snapshot of the global therapeutic landscape of Open-Angle Glaucoma
• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in the therapeutics development for Open-Angle Glaucoma and enlists all their major and minor projects
• The report summarizes all the dormant and discontinued pipeline projects 
• A review of the Open-Angle Glaucoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Reasons to buy

• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop strategic initiatives by understanding the focus areas of leading companies
• Identify and understand important and diverse types of therapeutics under development for Open-Angle Glaucoma
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=245117